Both in Pharmaceuticals
PUMA BIOTECHNOLOGY vs Shattuck Labs
Over the past year PBYI returned +102.8% and STTK returned +174.9%; their daily moves had a correlation of 0.26.
PBYI +102.8% STTK +174.9%Growth of $1, one year, split-adjusted
| Metric | PBYI | STTK |
|---|---|---|
| Price | $10.22 | $5.47 |
| Market cap | $527.6M | $549.0M |
| Today | +0.39% | +2.82% |
| 1 month | +5.7% | −15.8% |
| 6 months | +39.0% | −16.4% |
| Year to date | +71.8% | +49.9% |
| 1 year | +100.4% | +184.9% |
| Revenue growth (YoY) | +7.8% | — |
| Gross margin | 77.9% | — |
| Net margin | 14.5% | — |
| P/E (TTM) | 19.7× | — |
| Price / sales | 2.3× | 549.0× |
| Net cash | $93.9M | $208.3M |
| Dividend yield | — | — |
| Volatility (60d) | 39.5% | 58.5% |
| Short % of float | 11.6% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).